Briggs C, Culp N, Davis B, d'Onofrio G, Zini G, Machin S J
Int J Lab Hematol. 2014 Dec;36(6):613-27. doi: 10.1111/ijlh.12201. Epub 2014 Mar 25.
This revision is intended to update the 1994 ICSH guidelines. It is based on those guidelines but is updated to include new methods, such as digital image analysis for blood cells, a flow cytometric method intended to replace the reference manual 400 cell differential, and numerous new cell indices not identified morphologically are introduced. Haematology analysers are becoming increasingly complex and with technological advancements in instrumentation with more and more quantitative parameters are being reported in the complete blood count. It is imperative therefore that before an instrument is used for testing patient samples, it must undergo an evaluation by an organization or laboratory independent of the manufacturer. The evaluation should demonstrate the performance, advantages and limitations of instruments and methods. These evaluations may be performed by an accredited haematology laboratory where the results are published in a peer-reviewed journal and compared with the validations performed by the manufacturer. A less extensive validation/transference of the equipment or method should be performed by the local laboratory on instruments prior to reporting of results.
本次修订旨在更新1994年国际血液学标准化委员会(ICSH)指南。它以这些指南为基础,但进行了更新,纳入了新方法,如血细胞数字图像分析、一种旨在取代参考手册中400个细胞分类计数的流式细胞术方法,并且引入了许多无法通过形态学识别的新细胞指数。血液学分析仪正变得越来越复杂,随着仪器技术的进步,全血细胞计数报告的定量参数越来越多。因此,在使用仪器检测患者样本之前,必须由独立于制造商的组织或实验室进行评估,这一点至关重要。评估应证明仪器和方法的性能、优点和局限性。这些评估可由认可的血液学实验室进行,其结果发表在同行评审期刊上,并与制造商进行的验证进行比较。在报告结果之前,当地实验室应对仪器进行不太全面的设备或方法验证/转移。